Takeda Pharmaceutical Cash Flow Statement (2017-2025) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income	0.37B	-1.37B	1.01	0.77	0.51B	2.40B	0.06B	-0.24B	0.75B	2.83B	1.66B	-0.13B	1.22B	1.86B	2.82B	0.70B	0.76B	2.65B	0.81B	0.49B	0.67B	1.56B	0.65B	2.25B	1.76B	0.61B	1.14B	7.40B	1.32B	2.81B	2.62B	7.49B	1.07B
Deferred Taxes						0.60B
Gains from Investment Securities			-0.13B	-0.06B	-0.07B	0.17B	-0.54B	-0.35B	-1.04B	-0.22B	-0.48B	-0.49B	-0.68B	-0.58B	-0.33B	-0.39B	-0.25B	-0.35B	-0.19B	-0.66B	-0.41B	-0.19B	-0.41B	-0.51B	-0.34B	-0.27B	-0.24B	-0.34B	-0.21B	-0.33B	-0.25B	-0.37B	-0.16B
Asset Writedowns and Impairment			0.00B	0.01B	0.06B	0.02B	0.16B	0.01B	0.15B	0.61B	0.07B	0.01B	0.02B	0.14B	0.00B	0.01B	0.12B	0.34B	0.11B	0.16B	0.04B	0.17B	0.06B	0.82B	0.05B	0.11B	0.17B	0.07B	0.01B	0.45B	0.02B	0.58B	0.05B
Cash from Operations		1.44B	0.37B	0.69B	0.83B	1.10B	1.10B	4.51B	1.32B	1.34B	1.36B	2.32B	2.09B	5.69B	1.52B	2.12B	3.06B	4.44B	0.65B	1.60B	2.68B	3.63B	0.67B	1.38B	0.99B	3.24B	1.09B	1.88B	2.52B	2.44B	1.49B	2.57B	2.42B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles			-0.22	-0.22			-0.96	-0.95
Amortization	0.24B				-0.73B	-1.18B				15.43B
Depreciation & Amortization (CF)		0.36B	0.35B	0.35B	0.34B	1.19B	1.37B	1.33B	1.33B	1.34B	1.32B	1.31B	1.34B	1.32B	1.31B	1.28B	1.30B	1.31B	1.22B	1.22B	1.25B	1.22B	1.25B	1.27B	1.27B	1.26B	1.23B	1.29B	1.23B	1.24B	1.26B	1.26B	1.24B
Change in Working Capital
Change in Receivables		0.71B	-0.38B	-0.03B	-0.51B	0.81B	-0.41B	-0.08B	-0.14B	0.31B	-0.24B	0.23B	-0.46B	0.38B	-0.38B	-0.12B	1.21B	0.39B	-0.14B	0.09B	0.09B	0.52B	-0.66B	0.12B	0.10B	0.50B	-0.31B	-0.07B	0.08B	-0.09B	0.33B	-0.07B	-0.07B
Change in Inventory		0.06B	-0.11B	-0.08B	0.05B	0.60B	0.39B	0.17B	0.29B	0.41B	-0.04B	0.07B	0.03B	0.19B	-0.19B	-0.04B	-0.13B	-0.06B	-0.07B	-0.05B	-0.13B	-0.34B	-0.21B	-0.34B	-0.34B	0.09B	-0.06B	-0.28B	0.14B	-0.03B	-0.09B	-0.20B	-0.25B
Change in Account Payables		0.06B	-0.04B	0.04B	0.22B	-0.37B	-0.28B	-0.10B	0.02B	0.09B	-0.22B	-0.03B	0.20B	0.39B	-0.23B	0.14B	0.06B	1.09B	-0.75B	-0.29B	-0.05B	0.45B	-0.25B	-0.10B	0.48B	-0.21B	-0.24B	0.00B	0.13B	0.07B	-0.19B	0.11B	0.02B
Change in Taxes			0.14B	0.17B			-0.04B	-0.36B													-0.08B	0.13B			-0.30B	-0.30B			0.02B	-0.03B
Investing Activities
Capital Expenditures		1.07B	-0.18B	-0.16B	-0.12B	1.16B	-0.27B	-0.24B	-0.32B	1.99B	-0.22B	-0.26B	-0.24B	1.76B	-0.27B	-0.28B	-0.24B	1.81B	-0.33B	-0.21B	-0.24B	1.86B	-0.34B	-0.26B	-0.32B	2.07B	-0.37B	-0.33B	-0.30B	2.31B	-0.33B	-0.27B	-0.27B
Sales of Property, Plant and Equipment		0.01B	0.05B	0.00B	0.00B	0.41B	0.00B	-0.00B	0.00B	0.11B	0.00B	0.36B	0.04B	0.03B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	-0.00B	0.01B	0.00B	0.06B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.04B		0.00B
Change in Intangibles			-0.14B	-0.05B	-0.16B	-0.16B	-0.12B	-0.08B	-0.40B	-0.24B	-0.16B	-0.12B	-0.18B	-0.72B	-0.11B	-0.12B	-0.19B	-0.14B	-0.43B	-0.08B	-0.12B	-3.09B	-1.63B	-0.22B	-0.20B	-0.13B	-0.52B	-0.08B	-0.08B	-0.29B	-0.19B	-0.09B	-1.16B
Acquisitions			-0.55B	-0.06B		-26.27B	-0.04B	0.00B	-0.00B	-0.00B					-0.25B		-0.19B
Divestments					0.00B	0.52B				0.79B			0.90B	3.83B	0.02B			0.22B					0.00B	-0.00B		0.13B	0.02B	0.04B	0.01B	0.07B	0.20B	0.00B	0.02B
Change in Acquisitions & Divestments		-0.10B	-0.12B	-0.20B	-0.04B	0.29B	-0.12B	-0.02B	0.29B	-0.28B	-0.35B	-0.02B	0.27B	0.01B	-0.32B	0.16B	0.12B	-0.02B	-0.32B	0.22B	0.23B	-0.18B	-0.49B	-0.05B	0.18B	0.29B	-0.71B	-0.06B	0.25B	0.53B	-0.60B	0.35B	0.32B
Cash from Investing Activities		-0.99B	-0.16B	0.13B	-14.29B	-0.38B	-0.38B	-15.04B	-0.69B	-0.38B	0.01B	0.26B	0.69B	2.77B	-0.64B	-0.30B	-0.61B	-0.22B	-0.73B	-0.20B	-0.33B	-3.31B	-1.94B	-0.42B	-0.51B	-0.41B	-1.01B	-0.50B	-0.76B	-0.13B	-0.23B	-0.33B	-1.49B
Financing Activities
Other financing activities	25.08B		-0.02B			0.20B	-0.02B			-0.02B
Cash from Financing Activities		-1.38B	-0.75B	-0.13B	13.38B	-1.61B	-1.62B	13.16B	-0.46B	-1.77B	-1.79B	-2.12B	-2.87B	-3.50B	-3.75B	-2.25B	-1.48B	-2.10B	-1.67B	-0.38B	-3.08B	-0.05B	-0.42B	-0.97B	-0.66B	-0.39B	2.03B	-0.74B	-4.31B	-1.98B	-1.49B	-0.08B	-1.25B
Dividend Payments
Dividends Paid - Common		2.58B	-0.60B	-0.06B	-0.57B	2.53B	-1.21B	-0.08B	-1.23B	5.12B	-1.24B	-0.08B	-1.27B	5.28B	-1.21B	-0.09B	-1.16B	4.80B	-1.00B	-0.08B	-0.91B	4.15B	-0.95B	-0.06B	-0.94B	3.82B	-0.89B	-0.06B	-0.96B	3.91B	-1.00B	-0.06B	-0.97B
Additional items
Exchange Rate Effect		-0.04B	-0.00B	0.04B	-0.09B	-0.10B	-0.10B	0.12B	0.05B	-0.10B	-0.01B	-0.07B	-0.03B	0.23B	0.03B	0.00B	0.05B	0.17B	0.17B	0.07B	-0.07B	-0.00B	0.11B	0.03B	-0.02B	0.07B	0.11B	-0.28B	0.15B	-0.06B	-0.02B	0.09B	0.15B
Change in Cash		-1.22B	-0.54B	0.69B	-0.08B	-0.89B	-0.90B	-1.13B	0.18B	-0.90B	-0.43B	0.45B	-0.10B	3.06B	-2.87B	-0.43B	0.97B	0.91B	-1.75B	1.03B	-0.73B	-1.14B	-1.69B	-0.02B	-0.18B	1.07B	2.12B	0.64B	-2.55B	-0.65B	-0.23B	2.16B	-0.32B
Free Cash Flow		0.37B	0.55B	0.85B	0.94B	-0.07B	1.37B	4.75B	1.64B	-0.65B	1.57B	2.58B	2.32B	3.93B	1.80B	2.40B	3.30B	2.63B	0.98B	1.81B	2.91B	1.77B	1.01B	1.64B	1.31B	1.18B	1.46B	2.22B	2.82B	0.13B	1.82B	2.84B	2.70B
Net Cash Flow		-0.94B	-0.54B	0.69B	-0.08B	-0.89B	-0.90B	2.63B	0.18B	-0.81B	-0.43B	0.45B	-0.10B	4.97B	-2.87B	-0.43B	0.97B	2.12B	-1.75B	1.03B	-0.73B	0.26B	-1.69B	-0.02B	-0.18B	2.44B	2.12B	0.64B	-2.55B	0.33B	-0.23B	2.16B	-0.32B

Research Tools

Takeda Pharmaceutical Cash Flow Statement (2017-2025) | TAK

Create an account

Sign In

Reset Password